Despite recent emerging evidence supporting a role for DNA methylation in regulating GPX4 expression and the widespread use of ferroptosis-related DNA methylation signatures as predictive and prognostic biomarkers for a wide range of cancers [82,83,84], DNA methylation in the ferroptosis sensitivity of LUAD remains relatively understudied. Here, GPX4 is linked to cancer.